Capsaicin vs Semaglutide

Head-to-head evidence comparison — which supplement is right for you?

Quick answerNo interaction data — ask a pharmacist

Capsaicin vs Semaglutide: Semaglutide has the stronger overall evidence (8.5 vs 5/10); they're alternatives for manage weight — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.

Semaglutide Edges Ahead

Semaglutide wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.

Capsaicin1 win

Semaglutide2 wins

Which is right for you? Take the 60-second quiz Open in the full comparison tool

Cap5.0

Capsaicin

Too few graded studiesHigh safety

Sgl8.5

Semaglutide

Too few graded studiesLimited safety

Evidence

Evidence Score

5/10

Studies: 189

Meta-analyses: 26

Level: Moderate

Evidence Score

Best8.5/10

Studies: 449

Meta-analyses: 130

Level: Very Strong

Research findings

Verdict

Too few graded studies

Top outcomes

Weight managementToo few graded studies11
Glucose & metabolicToo few graded studies2

Verdict

Too few graded studies

Top outcomes

Blood sugar & glycemic controlToo few graded studies197
Weight managementToo few graded studies180
Cardiovascular outcomesToo few graded studies57

Shared outcomes (2)

Outcomes where both Capsaicin and Semaglutide have evidence — compare verdict strength side-by-side.

Blood sugar & glycemic controlToo few graded studies2Too few graded studies197
Weight managementToo few graded studies11Too few graded studies180

Dosage & timing

Recommended Dosage:

2-6mg capsaicinoids daily (meta-analysis suggests a minimum of ~2mg to affect energy intake); higher capsinoid doses used for thermogenesis (a typical label dose, no cited trial states the dose it used)

Warnings

Effects on weight and metabolism are small — not a standalone weight-loss treatment
Topical capsaicin products for pain are regulated drugs and are NOT the same as this oral supplement

Best Time:

Before meals

Can take on empty stomach

Best Form:

Capsaicinoid extract (capsule)

Recommended Dosage:

Prescription-only, clinician-titrated. Subcutaneous (Wegovy weight management: escalate to 2.4 mg once weekly; Ozempic diabetes: 0.5-2.0 mg once weekly). Oral (Rybelsus diabetes: 3-14 mg once daily). DO NOT self-dose.

Warnings

This is a PRESCRIPTION DRUG, not a dietary supplement — use only under a clinician's care for an approved medical indication.
US FDA labeling includes a boxed warning about thyroid C-cell tumors: semaglutide caused these tumors in rodents; relevance to humans is uncertain. Under the US label it is contraindicated with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2. For treatment in Germany or Austria, consult the current EU product information for the exact medicine’s locally approved indications, contraindications and warnings; discuss any thyroid history with the prescriber.
Risk of acute pancreatitis — discontinue and seek care for severe persistent abdominal pain.
Risk of gallbladder disease (gallstones, cholecystitis), particularly with rapid weight loss.
Gastrointestinal adverse effects (nausea, vomiting, diarrhea, constipation) are very common, especially during dose escalation.
Post-marketing reports of ileus (severely slowed gut motility).
May worsen pre-existing diabetic retinopathy, attributed to rapid improvement in glucose control — ensure ophthalmologic monitoring in patients with a history of diabetic retinopathy.
Weight loss includes loss of lean muscle mass — pair with resistance training and adequate protein.
FDA has warned about COMPOUNDED / grey-market semaglutide: risk of dosing errors, impurities, and unapproved salt forms. Use only pharmacy-dispensed product.
Not for cosmetic weight loss without a genuine medical indication.
May increase hypoglycemia risk when combined with insulin or sulfonylureas (dose adjustment needed).

Best Time:

Any time of day

Can take on empty stomach

Best Form:

Subcutaneous once-weekly injection (Ozempic / Wegovy)

Safety

High safetyBest

Drug Interactions:

Antihypertensive drugs (mild)

Side Effects:

GI/oral burning, heartburn, stomach discomfortTransient rise in heart rate

Contraindications:

Active peptic ulcer or significant GERD (may aggravate)
Known capsaicin intolerance

Limited safety

Drug Interactions:

Other GLP-1 receptor agonists (severe)
Insulin and sulfonylureas (moderate)
Oral medications (general) (moderate)

Side Effects:

NauseaVomiting / diarrhea / constipationGallbladder disease (cholelithiasis / cholecystitis)

Contraindications:

Personal or family history of medullary thyroid carcinoma (MTC) (a contraindication under the US label)
Multiple Endocrine Neoplasia syndrome type 2 (MEN2) (a contraindication under the US label)

Shared goals

Manage weightSemaglutide

Capsaicin50/100

Semaglutide88/100

Metabolic healthSemaglutide

Capsaicin44/100

Semaglutide70/100

What you'll notice

🔥 Increased thermogenesis / metabolic ratepositive

Acute (per dose)

🍽️ Reduced appetite / energy intakepositive

Acute (per meal)

🌶️ GI/oral burning sensationnegative

Acute

ℹ️ Small effect magnitudeneutral

Throughout use

🩸 Improved glycemic controlpositive

Weeks to months

⚖️ Substantial weight losspositive

Months (titrated over 16-20 weeks)

❤️ Reduced cardiovascular eventspositive

Months to years

🤢 GI adverse effects (very common)trade-off

Especially during dose escalation

Key studies

Could capsaicinoids help to support weight management? A systematic review and meta-analysis of energy intake data.

Appetite (2014) · Meta analysis · n=191

Pooled 8 trials (191 participants), 19 effect sizes

The effect of Capsaicinoids or Capsinoids in red pepper on thermogenesis in healthy adults: A systematic review and meta-analysis.

Phytother Res (2021) · Meta analysis

Pooled 13 placebo-controlled trials

The effects of capsaicin and capsiate on energy balance: critical review and meta-analyses of studies in humans.

Chem Senses (2012) · Meta analysis

Meta-analyses of thermogenic outcomes plus systematic review of appetite outcomes in humans

All Capsaicin studies

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).

N Engl J Med (2021) · Rct · n=1961

Double-blind RCT in 1,961 adults with obesity/overweight WITHOUT diabetes, randomized 2:1 to subcutaneous semaglutide 2.4 mg/week or placebo plus lifestyle for 68 weeks

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT).

N Engl J Med (2023) · Rct · n=17604

Large cardiovascular-outcomes RCT: 17,604 patients with preexisting cardiovascular disease and overweight/obesity but WITHOUT diabetes

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6).

N Engl J Med (2016) · Rct · n=3297

Pre-approval cardiovascular-safety RCT in 3,297 patients with type 2 diabetes at high cardiovascular risk, semaglutide (0.5/1.0 mg/week) vs placebo for 104 weeks

All Semaglutide studies

Frequently asked questions

Is Capsaicin better than Semaglutide?

Semaglutide has a higher evidence score (8.5/10 vs 5/10) and wins in 2 of 3 categories.

Is Capsaicin or Semaglutide better for manage weight?

For manage weight, Semaglutide has a higher relevance score (88 vs 50).

Can I take Capsaicin and Semaglutide together?

No documented interaction was found in the data searched. This does not establish that this exact combination is safe.

Related comparisons

Capsaicin vs Iron Capsaicin vs Whey Protein Capsaicin vs Tirzepatide Semaglutide vs Tirzepatide Liraglutide vs Semaglutide AREDS2 Formula vs Semaglutide

Still deciding between Capsaicin and Semaglutide?

The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.

Get your personalised pick Capsaicin details Semaglutide details

Warnings

This is a PRESCRIPTION DRUG, not a dietary supplement — use only under a clinician's care for an approved medical indication.

US FDA labeling includes a boxed warning about thyroid C-cell tumors: semaglutide caused these tumors in rodents; relevance to humans is uncertain. Under the US label it is contraindicated with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2. For treatment in Germany or Austria, consult the current EU product information for the exact medicine’s locally approved indications, contraindications and warnings; discuss any thyroid history with the prescriber.

Risk of acute pancreatitis — discontinue and seek care for severe persistent abdominal pain.

Risk of gallbladder disease (gallstones, cholecystitis), particularly with rapid weight loss.

Gastrointestinal adverse effects (nausea, vomiting, diarrhea, constipation) are very common, especially during dose escalation.

Post-marketing reports of ileus (severely slowed gut motility).

May worsen pre-existing diabetic retinopathy, attributed to rapid improvement in glucose control — ensure ophthalmologic monitoring in patients with a history of diabetic retinopathy.

Weight loss includes loss of lean muscle mass — pair with resistance training and adequate protein.

FDA has warned about COMPOUNDED / grey-market semaglutide: risk of dosing errors, impurities, and unapproved salt forms. Use only pharmacy-dispensed product.

Not for cosmetic weight loss without a genuine medical indication.

May increase hypoglycemia risk when combined with insulin or sulfonylureas (dose adjustment needed).

Frequently asked questions

Is Capsaicin better than Semaglutide?

Semaglutide has a higher evidence score (8.5/10 vs 5/10) and wins in 2 of 3 categories.

Is Capsaicin or Semaglutide better for manage weight?

For manage weight, Semaglutide has a higher relevance score (88 vs 50).

Can I take Capsaicin and Semaglutide together?

No documented interaction was found in the data searched. This does not establish that this exact combination is safe.